Enhancement of antitumor therapy with hemoglobin-based conjugate

Details Enhancement of antitumor therapy with hemoglobin-based conjugate Enhancement of antitumor therapy with hemoglobin-based conjugate

1995-10-16

1997-08-19

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530385, 604 20, A61K 3842, C07K 14805

Patent

active

056588798

ABSTRACT:
The use of hemoglobin-polymer conjugates to enhance antitumor therapy in mammals is disclosed. The methods include administering an effective amount of an antitumor therapy such as radiation in combination with hemoglobin conjugated to a substantially non-antigenic polymer.

REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4412989 (1983-11-01), Iwashita et al.
patent: 4861876 (1989-08-01), Kessel
patent: 5122614 (1992-06-01), Zalipsky
patent: 5173426 (1992-12-01), Fischer et al.
patent: 5234903 (1993-08-01), Nho et al.
patent: 5239061 (1993-08-01), Fronticelli et al.
patent: 5264555 (1993-11-01), Shorr et al.
patent: 5295944 (1994-03-01), Teicher et al.
patent: 5296465 (1994-03-01), Rausch et al.
patent: 5296466 (1994-03-01), Kilbourn et al.
patent: 5312808 (1994-05-01), Shorr et al.
patent: 5478806 (1995-12-01), Nho
Teicher et al., "Effect of various oxygenation conditions and fluosol-DA on cnacer chemotherapeutics Agents", Biomat., Art. Cells, Art. Org. vol. 16(1-3), pp. 533-546 1988.
Teicher et al., Art. Cells, Blood Subs., and Immob. Biotech. 22(3) 827-833 (1994).
Teicher, Biomat., Art. Cells & Immob. Biotech., 20(2-4), Var. 875-910 (1992).
Nho et al, "Increased Oxy. Ten. in Sol. Tum. following PEG-Hb trans.", Blood Substitutes & Related Prod., IBC, Philadelphia, (Sep. 21-22, 1993).
Hirst et al Br. J. Cancer, 55, 487-491 (1987).
Siemann et al, Int. J. Radiation Oncol. Biol. Phys., 16, 1169-1172 (1989).
Teicher et al, J. Cancer Res. Clin. Oncol., 118, 123-128 (1992).
Wu et al, Cancer Res., 53, 3765-3770 (Aug. 15, 1993).
Winslow, "Hemoglobin Based Blood Substitutes", Blood Substitutes & Related Products, IBC, Philadelphia (Sep. 21-22, 1993).
Coleman, Astro Refresher Course #409 "Hypoxic Cell Sensitizers" (Oct. 18, 1990).
Teicher et al, Biomat., Art. Cells, Art. Org., 16(1-3) 533-546 (1988).
Rockwell, Biomat., Art. Cells, Art. Org., 16(1-3), 519-531 (1988).
Teicher et al, Biomat., Art. Cells & Immob. Biotech. 20(2-4), 657-660 (1992).

Affiliated with

Also associated with

Rating

Enhancement of antitumor therapy with hemoglobin-based conjugate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhancement of antitumor therapy with hemoglobin-based conjugate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of antitumor therapy with hemoglobin-based conjugate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1104782